THE TAPE

Oneok, Inc.

$88.08▼ −1.86%
Last close
Relative strength
47RS
of 99, against every stock▼ -24 on the month
Falling back
Caution
−6.2%
six months against the S&P 500
52-week range
−11.8%
from the high
$68.20$99.84
Setup
flat baseplayed out
−8.3%
against the pivot at $96.07
No report date on the calendar.
Growth REALProof SHOWN
Quarter to Sep 30, revenue +44% on a year ago
11/16 O 89.10 H 89.56 L 87.60 Vol 2.8M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS47
vs pivot−8.31%
Tightening1.06×
Dry-up1.10×
Up/down vol0.08
From high12%
played out4 of 9checks
Falling back
Support and resistance
Support below
$83.74
-4.9% · tested 4× · last 4 sessions ago
Resistance above
$90.63
+2.9% · tested 7× · last 17 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 12.2 weeks and fell 14% from its ceiling at its deepest. The pivot is $96.07, and the stock closed 8.3% below it. Its relative strength rating is 47.

Against its industry
CautionBehind its industry over all three, in an industry that is not ahead of the S&P 500.
One month against the S&P 500
-2.6%
Three months against the S&P 500
-5.9%
Six months against the S&P 500
-6.2%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 3.5% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$43.2B
+44.3% year on year
Operating margin
14.2%
Net margin
9.4%
Free cash flow
$2.5B
4.6% of market cap
Price to sales
1.29×
Price to earnings
13.7×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 27
Key takeaway
Growth with the cash to show for it: the quarter confirms the thesis.
Revenue
$12.5B
+3.4% QoQ · +44.3% YoY
Gross margin
—
Net income
$1.4B
Positive
Free cash flow
$442.0M
Cash generating

What the numbers say

  • Good: Revenue +44.3% year over year, +3.4% on the quarter
  • Good: Profitable: net income $1.35B, operating margin 12.6%
  • Good: Cash generating: operating cash flow $1.38B, free cash flow $442M
  • Weak: Net debt $28.25B · cash $186M
Revenue by quarter
Free cash flow
Net income
shares +0.2% in a year · net debt $28.2B

What is not obvious

  • Contracted backlog (remaining performance obligations) $6.64B, 0.2× trailing revenue, -2% on the quarter. Backlog is not recognised revenue
Final read
Growth: REAL · Economic proof: SHOWN
Key question: Does the next quarter repeat this one?
The next test is the balance sheet: net debt $28.25B · cash $186M.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep
Closed below its 20- and 50-day on heavy volumeTape · 2026-11-11
below 20d & 50d on 1.6x volume at 87.37
No measurable effect: stocks behave like random ones over the next three sessions (1,780 cases over 60 nights).
Closed below its 20- and 50-day on heavy volumeTape · 2026-11-05
below 20d & 50d on 1.8x volume at 88.60
No measurable effect: stocks behave like random ones over the next three sessions (1,780 cases over 60 nights).
Unusual volumeTape · 2026-11-05
3.5 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Reported resultsFiling · 2026-10-28
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Unusual volumeTape · 2026-09-19
10.7 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders

Nobody bought or sold on the open market in the last 6 months. There were 11 filings for awards, option exercises or shares withheld to pay tax — those happen on a vesting schedule, so they are not a decision to buy or sell.

Most recent filings
2026-09-23 SPEARS MARY M · See Remarksoption exercise2,316
2026-09-23 SPEARS MARY M · See Remarkswithheld for tax1,016$91,531
2026-09-23 HULSE WALTER S III · See Remarksoption exercise7,238
2026-09-23 HULSE WALTER S III · See Remarkswithheld for tax3,174$285,946
2026-09-23 SWORDS SHERIDAN C · See Remarksoption exercise4,343
2026-09-23 SWORDS SHERIDAN C · See Remarkswithheld for tax1,905$171,621
2026-09-23 Taylor Lyndon C · See Remarksoption exercise6,369
2026-09-23 Taylor Lyndon C · See Remarkswithheld for tax2,793$251,621

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

4 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy3
Buy7
Hold13
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray
12w · 14%

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Oneok, Inc. (OKE) — The Tape